900 La Torre G et al. 36. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18(6):551-7. 37. Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissa- ris D, et al. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology. 2000;47(33):782-5. 38. Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology. 2005;42(6):1406-13. 39. Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepa- titis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis. 2010;14(2):e115-20. 40. Naoumov NV. Hepatitis C virus infection in Eastern Europe. J Hepatol. 1999;31(Suppl 1):84-7. 41. Nkengasong JN, De Beenhouwer H, Claeys H, Nyambi P, Ayuk J, HCV Trends in Italy van der Groen G, et al. A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Camer- oon. Am J Trop Med Hyg. 1995;52(1):98-100. 42. Znyk M. [Hepatitis C in lodzkie voivodeship in 2003-2008]. Przegl Epidemiol. 2010;64(3):367-72. 43. Spada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, et al. Changing epidemiology of parenterally transmitted viral hepa- titis: results from the hepatitis surveillance system in Italy. Dig Liver Dis. 2001;33(9):778-84. 44. Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol. 2008;42(5):527-32. 45. Recommendations for prevention and control of hepatitis C vi- rus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47(RR- 19):1-39. Hepat Mon. 2011;11(11):895-900